Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Neoplasms 1Nausea 1Head and Neck Neoplasms 1Advanced Solid Tumor 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Injections, Intravenous × Clear all
NCT04718376 2024-03-07

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Terminated
56 enrolled
Gynecologic

Ovarian Neoplasms

NCT04902027 2024-03-07

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Completed
45 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04719065 2021-11-01

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
90 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡